RECRUITING

Ventilatory and Perfusion Abnormalities in Individuals with Post-Acute Sequelae of SARS-CoV-2 Infection

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Prospective cohort study to evaluate the utility of quantitative CT analysis to assess ventilation and perfusion defects in patients with Post-acute Sequelae of SARS-CoV-2 (PASC) and functional limitations

Official Title

Quantitative Computed Tomography to Assess Ventilatory and Perfusion Abnormalities in Individuals with Post-Acute Sequelae of SARS-CoV-2 Infection

Quick Facts

Study Start:2023-06-05
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05866952

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 18
  2. * Self-reported or documented SARS-CoV-2 infection by RT-PCR or Antigen testing \> 3 months ago or no previous history of SARS-CoV-2 infection (control group only)
  3. * Normal or mild abnormalities on baseline Pulmonary Function Tests (PFTs)
  4. * New or worsening symptoms of chronic fatigue, dyspnea or exercise intolerance after COVID-19 with otherwise unclear etiology (PASC group only)
  1. * SARS-CoV-2 infection by RT-PCR or Antigen testing within the last 3 months
  2. * Inability to provide consent or non-English speaking
  3. * Pregnancy
  4. * Any respiratory infection in last 4 weeks
  5. * PFT relative contraindications
  6. * History of major cardiovascular, pulmonary, renal, hepatic, autoimmune or neuromuscular disease including asthma, COPD, interstitial lung disease, heart failure, pulmonary arterial hypertension, or prior pulmonary embolism
  7. * Active malignancy undergoing treatment or history of malignancy involving the lung

Contacts and Locations

Study Contact

Bipin Malla
CONTACT
617-636-6304
tuftsmccorstudy@tuftsmedicalcenter.org

Study Locations (Sites)

Tufts Medical Center
Boston, Massachusetts, 02111
United States

Collaborators and Investigators

Sponsor: Tufts Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-05
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2023-06-05
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Ventilation Perfusion Mismatch

Additional Relevant MeSH Terms

  • Post-Acute COVID-19
  • Post COVID-19 Condition
  • Post Viral Fatigue
  • Dyspnea